CLOV vs DBD
Clover Health Investments Corp (CLOV) versus Diebold Nixdorf, Incorporated (DBD) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
CLOV currently screens at market cap $1.55B. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Not investment advice. Open the CLOV and DBD stock pages for the full models.
Not investment advice.